Lixte Biotechnology Holdings, Inc.
LIXT • NASDAQ
Lixte Biotechnology Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Geordan G. Pursglove, with a market cap of $40.4M.
Market Cap$40.4M
Employees4.0
CEOGeordan G. Pursglove
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Lixte Biotechnology Holdings, Inc. FAQ
Common questions about Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026 before market open.
Lixte Biotechnology Holdings, Inc. has approximately 4 employees.